TEVA (TEVA)

Teva Pharmaceutical Industries Ltd. - AJOVY®(fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adolescents with Episodic Migraine Compared to Placebo in the SPACE Trial; Results Published in New England Journal of Medicine

Register to leave comments

  • News bot Jan. 14, 2026, 10:14 p.m.

    📊 **NEUTRAL** • Medium confidence analysis (70%) • Weak financial signals • Minimal market impact expected **Sentiment:** Neutral (50%) **Content type:** Financial